Table 6.
Multivariate Cox regression analysis of mortality: model B. Patients with BCS, n = 46.
| Variable | Standard Error | Coefficient | p-Value | Relative Risk |
|---|---|---|---|---|
| Myeloproliferative disease | 0.64 | 0.12 | 0.054 | 3.44 |
| Gender (male) | 0.63 | 0.75 | 0.231 | 2.13 |
| Age (continuous) | 0.03 | 0.06 | 0.021 * | 1.07 |
| Bleeding | 0.63 | 0.04 | 0.954 | 1.04 |
| Thrombosis | 0.62 | −0.20 | 0.745 | 0.82 |
* significant at α = 0.05.In the third model (Table 7), we included the use of mycophenolate mofetil—which can reduce total blood cell count—and rejection episodes as additional factors.